Home> Products> qt pine sr 300 tablet

{ "products": [ { "_id": "68c29ba02244c906e7790e2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg", "description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\nKey Indications:\n\nTELAVINCE 300 is indicated for:\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\nDosage and Administration:\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\nKey Benefits of TELAVINCE 300:\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\nDiarrhea\nHeadache\nFatigue\nRash\nDizziness\nDecreased bone mineral density\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\nProtect from light and moisture.\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.", "price": 1480.0, "discountamount": 444.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2179, "imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png", "tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-11T09:51:28.508Z", "updatedon": "2025-12-09T06:12:21.303Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tenofovir-disoproxil-fumarate-tablets-ip-300-mg/2179", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TELAVINCE 300", "category": "GENERAL RANGE", "tags": [ "Tenofovir Disoproxil Fumarate 300 mg", "HIV-1 infection", "TELAVINCE 300", "Lactic Acidosis and Hepatomegaly" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666c0208d89239081848a527", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "STARGAB 300 ", "description": "STARGAB 300 \nGabapentin 300 mg\nIntroduction:\n\nSTARGAB 300 contains Gabapentin, a versatile anticonvulsant and neuropathic pain agent widely used to manage conditions such as epilepsy and neuropathic pain. With a dosage strength of 300mg, STARGAB 300 aims to alleviate symptoms by modulating neurotransmitter release, thereby improving quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nSTARGAB 300 works by stabilizing electrical activity in the brain, making it an effective treatment for various types of seizures in patients with epilepsy. It helps reduce the frequency and severity of seizures, enhancing overall neurological stability.\nNeuropathic Pain Relief:\n\nGabapentin is particularly effective in managing neuropathic pain, which is pain caused by nerve damage. It helps reduce pain sensations, providing relief for conditions such as diabetic neuropathy, postherpetic neuralgia, and spinal cord injury-related pain.\nImproved Sleep Quality:\n\nPatients suffering from chronic pain often experience disrupted sleep. STARGAB 300 can improve sleep quality by alleviating pain, leading to better rest and overall well-being.\nMood Stabilization:\n\nIn addition to its primary uses, Gabapentin has been shown to have mood-stabilizing properties, making it beneficial for patients with mood disorders coexisting with neuropathic pain or epilepsy.\nWell-Tolerated and Safe:\n\nGabapentin is generally well-tolerated, with a favorable safety profile, making STARGAB 300 a reliable option for long-term management of neuropathic pain and seizures.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe recommended starting dose of STARGAB 300 for epilepsy is 300mg once daily on the first day, 300mg twice daily on the second day, and 300mg three times daily on the third day. The dose can be gradually increased based on clinical response and tolerability, with a maintenance dose typically ranging from 900mg to 1800mg per day, divided into three doses.\nInitial Dosage for Neuropathic Pain:\n\nFor neuropathic pain, the initial dose is typically 300mg taken once daily, gradually increasing to 300mg three times daily, based on patient response and tolerability. The maintenance dose may range from 900mg to 3600mg per day, divided into multiple doses.\nAdministration Instructions:\n\nSTARGAB 300 tablets should be taken orally with or without food. It is advisable to take the medication at the same time each day to maintain consistent therapeutic levels in the bloodstream.\nContinued Monitoring:\n\nRegular monitoring of symptoms, pain levels, and potential side effects is essential during STARGAB 300 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/stargab-300-134312", "price": 155.0, "discountamount": 46.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "rest", "life", "food", "brain", "EMAIL", "option", "epilepsy", "seizures", "addition", "symptoms", "severity", "Benefits", "patients", "same time", "first day", "third day", "frequency", "second day", "conditions", "Gabapentin", "medication", "information", "bloodstream", "pain levels", "three doses", "nerve damage", "Introduction", "sterispharma", "initial dose", "tolerability", "primary uses", "chronic pain", "Key Features", "sterisonline", "various types", "CALL/WHATSAPP", "starting dose", "multiple doses", "mood disorders", "patient safety", "Initial Dosage", "dosage strength", "pain sensations", "patient response", "maintenance dose", "clinical response", "Regular monitoring", "overall well-being", "Mood Stabilization", "STARGAB 300 tablets", "STARGAB 300 therapy", "electrical activity", "diabetic neuropathy", "effective treatment", "long-term management", "Continued Monitoring", "therapeutic efficacy", "Anticonvulsant Action", "neuropathic pain agent", "potential side effects", "postherpetic neuralgia", "Improved Sleep Quality", "Neuropathic Pain Relief", "favorable safety profile", "neurotransmitter release", "versatile anticonvulsant", "mood-stabilizing properties", "Administration Instructions", "consistent therapeutic levels", "overall neurological stability", "spinal cord injury-related pain" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1899, "imageuri": "https://productimages.withfloats.com/actual/666c020b8c6c791fd3b7131b.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c020b8c6c791fd3b7131b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T08:40:40.129Z", "updatedon": "2024-06-29T12:26:43.183Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/stargab-300-/1899", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "STARGAB 300 ", "category": "NEUROLOGY RANGE", "tags": [ "stargab 300 uses in hindi", "stargab 300 price in hindi", "gabapentin 300mg used for", "gabapentin 300mg dosage", "maximum dosage of gabapentin for nerve pain" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666ae20ef7438b1754ba11bd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "QT-PINE SR 300 ", "description": "QT-PINE SR 300 \nQuetiapine Prolonged Release (300mg)\nIntroduction:\n\nQT-PINE SR 300 is a medication formulated with Quetiapine in a prolonged-release format, specifically designed to provide sustained therapeutic benefits for individuals dealing with various psychiatric disorders. Quetiapine, an atypical antipsychotic, is renowned for its effectiveness in managing schizophrenia, bipolar disorder, major depressive disorder (MDD), and related conditions.\nKey Features and Benefits:\n\nExtended Release Mechanism:\n\nQT-PINE SR 300 employs a prolonged-release mechanism to deliver Quetiapine gradually over an extended period. This feature ensures a consistent therapeutic concentration in the bloodstream, reducing the need for frequent dosing and enhancing treatment compliance.\nAntipsychotic and Mood-Stabilizing Properties:\n\nQuetiapine, the active ingredient in QT-PINE SR 300, acts by blocking dopamine and serotonin receptors in the brain. This action helps alleviate psychotic symptoms like hallucinations and delusions in schizophrenia and stabilizes mood swings in bipolar disorder, preventing manic and depressive episodes.\nAntidepressant Effects:\nQT-PINE SR 300 is prescribed for major depressive disorder (MDD) due to Quetiapine's antidepressant properties. It modulates serotonin and norepinephrine levels, alleviating depressive symptoms and improving overall mood and well-being.\nAnxiolytic Action:\n\nThe anxiolytic (anxiety-reducing) effects of Quetiapine contribute to its efficacy in managing anxiety disorders such as generalized anxiety disorder (GAD) and social anxiety disorder (SAD).\nDosage and Administration:\n\nInitial Dosage and Adjustment:\nThe typical starting dose of QT-PINE SR 300 is 300mg taken orally once daily, preferably in the evening due to potential sedative effects. Dosage adjustments may be made by your healthcare provider based on individual response and tolerability.\nAdministration Instructions:\nSwallow the QT-PINE SR 300 tablet whole with water, without crushing or chewing it. Adhere strictly to the prescribed dosing schedule to maintain therapeutic blood levels.\nDuration of Treatment:\nContinue taking QT-PINE SR 300 as directed by your doctor, even if symptoms improve. Abrupt discontinuation can lead to relapse or withdrawal symptoms.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW.", "price": 182.0, "discountamount": 55.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "GAD", "SAD", "need", "brain", "manic", "water", "300mg", "EMAIL", "doctor", "evening", "relapse", "Duration", "efficacy", "dopamine", "delusions", "medication", "qt-pine-sr", "well-being", "mood swings", "individuals", "information", "bloodstream", "sterispharma", "tolerability", "Introduction", "overall mood", "Key Features", "sterisonline", "effectiveness", "CALL/WHATSAPP", "schizophrenia", "hallucinations", "Initial Dosage", "extended period", "frequent dosing", "dosing schedule", "bipolar disorder", "active ingredient", "anxiety disorders", "Anxiolytic Action", "psychotic symptoms", "Dosage adjustments", "related conditions", "withdrawal symptoms", "serotonin receptors", "depressive episodes", "individual response", "healthcare provider", "depressive symptoms", "treatment compliance", "typical starting dose", "norepinephrine levels", "QT-PINE SR 300 tablet", "atypical antipsychotic", "Abrupt discontinuation", "Antidepressant Effects", "social anxiety disorder", "therapeutic blood levels", "prolonged-release format", "major depressive disorder", "antidepressant properties", "potential sedative effects", "Extended Release Mechanism", "Mood Stabilizing Properties", "Administration Instructions", "prolonged-release mechanism", "Quetiapine Prolonged Release", "generalized anxiety disorder", "various psychiatric disorders", "sustained therapeutic benefits", "consistent therapeutic concentration", "anxiolytic (anxiety-reducing) effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1884, "imageuri": "https://productimages.withfloats.com/actual/666ae213f068be46bdebab38.png", "tileimageuri": "https://productimages.withfloats.com/tile/666ae213f068be46bdebab38.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:11:58.983Z", "updatedon": "2025-12-12T08:27:37.9Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/qt-pine-sr-300-/1884", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "QT-PINE SR 300 ", "category": "NEUROLOGY RANGE", "tags": [ "qutipin 300 side effects", "quetiapine for sleep dosage", "qutipin is dangerous", "qutipin 25 uses", "quetiapine for sleep reviews" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666acc861542dd108c562398", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "OXCARBZEN 300 ", "description": "OXCARBZEN 300 \nOxcarbazepine IP (300mg)\nIntroduction:\n\nOXCARBZEN 300 contains Oxcarbazepine IP (300 mg), an antiepileptic medication used to manage and treat partial seizures in epilepsy. Oxcarbazepine works by stabilizing the electrical activity in the brain, preventing the excessive electrical discharges that cause seizures.\nKey Features and Benefits:\n\nSeizure Control: Oxcarbazepine effectively reduces the frequency and severity of partial seizures, improving the quality of life for individuals with epilepsy.\nMood Stabilization: Besides its antiepileptic properties, Oxcarbazepine has mood-stabilizing effects, making it beneficial for individuals with mood disorders associated with epilepsy.\nWell-Tolerated: Generally well-tolerated with a favorable side effect profile compared to other antiepileptic medications.\nOnce-Daily Dosing: The 300 mg dosage allows for flexible dosing schedules, making it easier for patients to adhere to their treatment regimen.\nProven Efficacy: Oxcarbazepine is a well-established medication with a strong track record of efficacy and safety in treating epilepsy.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of OXCARBZEN 300 is 300 mg per day, divided into two doses. The dosage may be gradually increased by a healthcare provider based on the patient's response to treatment and the severity of seizures.\nMaintenance Dosage: The usual maintenance dose ranges from 600 mg to 2400 mg per day, divided into two doses, depending on the patient's needs and response to therapy.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Oxcarbazepine at the same time each day to maintain consistent medication levels in the bloodstream.\nMissed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule. Do not take a double dose to make up for a missed one.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/oxcarbzen-300-133599", "price": 139.0, "discountamount": 41.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "life", "food", "brain", "water", "needs", "EMAIL", "tablet", "600 mg", "safety", "therapy", "2400 mg", "quality", "epilepsy", "response", "severity", "patients", "Benefits", "next dose", "OXCARBZEN", "same time", "two doses", "frequency", "individuals", "bloodstream", "information", "double dose", "Key Features", "Introduction", "sterispharma", "sterisonline", "300 mg dosage", "CALL/WHATSAPP", "Administration", "Initial Dosage", "mood disorders", "Seizure Control", "Proven Efficacy", "Oxcarbazepine IP", "regular schedule", "partial seizures", "treatment regimen", "Mood Stabilization", "Maintenance Dosage", "strong track record", "electrical activity", "healthcare provider", "typical starting dose", "usual maintenance dose", "mood-stabilizing effects", "antiepileptic properties", "flexible dosing schedules", "consistent medication levels", "favorable side effect profile", "other antiepileptic medications", "excessive electrical discharges" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1869, "imageuri": "https://productimages.withfloats.com/actual/667d17c36c582d228f458060.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d17c36c582d228f458060.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T10:40:06.29Z", "updatedon": "2024-06-27T07:41:54.774Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/oxcarbzen-300-/1869", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OXCARBZEN 300 ", "category": "NEUROLOGY RANGE", "tags": [ "OXCARBZEN 300mg", "Oxcarbazepine IP (300mg)", "oxcarbazepine 300 mg tablet uses", "oxcarbazepine side effects sexually" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666958a6d0d0330684bda1b5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BUPROTROP SR 150 ", "description": "BUPROTROP SR 150 \nBupropion HCI ER (150mg)\nIntroduction\nBUPROTROP SR 150 contains Bupropion Hydrochloride Extended-Release (150mg), a medication used to treat major depressive disorder (MDD) and aid in smoking cessation. Bupropion is known for its dual-action mechanism, enhancing mood and helping individuals quit smoking by reducing withdrawal symptoms and cravings.\n\nKey Ingredient and Its Benefits\nBupropion HCI ER (150mg)\nAntidepressant Properties: Bupropion acts as a norepinephrine-dopamine reuptake inhibitor (NDRI), increasing the levels of norepinephrine and dopamine in the brain. This helps improve mood, alleviate depressive symptoms, and boost energy levels.\nSmoking Cessation Aid: Bupropion is effective in helping individuals quit smoking by reducing cravings and withdrawal symptoms, making the process more manageable.\nNon-Sedating: Unlike many other antidepressants, Bupropion does not typically cause sedation or weight gain, making it a preferred choice for many patients.\nEnhanced Focus and Energy: By increasing norepinephrine and dopamine levels, Bupropion can enhance focus, concentration, and overall energy levels.\nBenefits of BUPROTROP SR 150\nEffective Depression Management: BUPROTROP SR 150 helps alleviate symptoms of major depressive disorder, improving mood, energy levels, and overall well-being.\nSmoking Cessation Support: It aids in smoking cessation by reducing cravings and withdrawal symptoms, increasing the chances of successfully quitting smoking.\nNon-Sedating and Weight-Neutral: Bupropion is less likely to cause sedation or weight gain compared to other antidepressants, making it a favorable option for long-term use.\nImproved Focus and Energy: The medication enhances focus and energy levels, which can be beneficial for individuals struggling with depressive symptoms and low motivation.\nDosage and Administration\nDosage\nDepression: The typical starting dosage for treating major depressive disorder is one tablet (150mg) taken once daily. Depending on the patient's response and tolerability, the dosage may be increased to 300mg per day, taken as two 150mg doses.\nSmoking Cessation: For smoking cessation, the recommended dosage is one tablet (150mg) taken once daily for the first three days, then increased to 300mg per day, taken as two 150mg doses.\nAdministration\nOral Use: Swallow the tablet whole with a full glass of water. Do not crush, chew, or break the tablet, as it is designed to release the medication slowly over time.\nConsistency: For optimal results, take BUPROTROP SR 150 at the same time each day to maintain an even level of the medication in your bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/buprotrop-sr-150-133540", "price": 129.0, "discountamount": 38.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "mood", "NDRI", "EMAIL", "brain", "water", "300mg", "choice", "option", "chances", "Neutral", "process", "sedation", "Oral Use", "response", "Benefits", "cravings", "same time", "full glass", "medication", "one tablet", "Consistency", "bloodstream", "weight gain", "information", "individuals", "Introduction", "sterispharma", "tolerability", "BUPROTROP SR", "sterisonline", "CALL/WHATSAPP", "long-term use", "concentration", "many patients", "Improved Focus", "Enhanced Focus", "low motivation", "Key Ingredient", "two 150mg doses", "optimal results", "dopamine levels", "Bupropion HCI ER", "first three days", "overall well-being", "withdrawal symptoms", "depressive symptoms", "overall energy levels", "dual-action mechanism", "Smoking Cessation Aid", "typical starting dosage", "major depressive disorder", "Smoking Cessation Support", "Antidepressant Properties", "many other antidepressants", "Effective Depression Management", "Administration Dosage Depression", "Bupropion Hydrochloride Extended-Release", "norepinephrine-dopamine reuptake inhibitor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1781, "imageuri": "https://productimages.withfloats.com/actual/666958a80b4fc76a999faccf.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666958a80b4fc76a999faccf.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T08:13:26.062Z", "updatedon": "2024-06-27T07:28:18.182Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/buprotrop-sr-150-/1781", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BUPROTROP SR 150 ", "category": "NEUROLOGY RANGE", "tags": [ "BUPROTROP SR 150 mg", "Bupropion HCI ER 150mg price", "bupron sr 150 side effects", "bupron sr 150 reviews", "bupron sr 150 price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Imatinib IP 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2025-12-18T07:41:25.851Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/imatinib-ip-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69400227de5d3e57a9340a50", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nebivolol and s-amlodipine Tablets 5/2.5 mg", "description": "NEBIVALVE AM is a combination tablet containing Nebivolol and S-Amlodipine, designed to provide effective management of hypertension (high blood pressure). Hypertension is a leading risk factor for cardiovascular diseases in India, including heart attacks, strokes, and kidney complications.\n\nThis dual-action formulation combines the benefits of Nebivolol, a cardio-selective beta-blocker, with S-Amlodipine, a calcium channel blocker, providing comprehensive blood pressure control. The combination helps relax blood vessels, improve blood flow, and reduce cardiac workload, offering a convenient and effective option for patients requiring combination therapy.\n\nUses\n\nNEBIVALVE AM is primarily prescribed for:\n\nEssential Hypertension\nLowers elevated blood pressure to reduce the risk of cardiovascular complications.\n\nCardiovascular Risk Reduction\nHelps in preventing heart attacks, strokes, and heart failure in high-risk patients.\n\nManagement of Stable Angina\nBy reducing cardiac workload and improving oxygen supply to the heart.\n\nCombination Therapy in Resistant Hypertension\nSuitable for patients who do not achieve target blood pressure with single-drug therapy.\n\nBenefits\n1. Dual Mechanism of Action\n\nNebivolol: Blocks beta-1 adrenergic receptors in the heart, reducing heart rate and cardiac output. It also promotes nitric oxide release, helping dilate blood vessels.\n\nS-Amlodipine: Relaxes vascular smooth muscles by blocking calcium channels, improving blood flow and reducing blood pressure.\n\n2. Effective Blood Pressure Control\n\nThe combination provides better blood pressure reduction compared to either drug alone, helping patients achieve their target levels faster.\n\n3. Cardiovascular Protection\n\nReduces strain on the heart, lowers risk of stroke, and supports overall heart health.\n\n4. Once-Daily Convenience\n\nThe tablet can be taken once daily, enhancing patient adherence to therapy.\n\n5. Well-Tolerated Formulation\n\nBoth Nebivolol and S-Amlodipine are generally well tolerated, minimizing side effects when used as prescribed.\n\nDosage\n\nTypical Dose: One tablet of NEBIVALVE AM once daily, preferably at the same time each day.\n\nAdministration: Swallow the tablet whole with water. Do not crush or chew.\n\nIndividualization: The dose may be adjusted by the physician based on blood pressure response and patient tolerability.\n\nLifestyle Measures: Continue dietary modifications, regular exercise, and salt restriction alongside medication for optimal results.\n\nImportant: Do not stop the medication abruptly without consulting your doctor, as sudden withdrawal may worsen blood pressure control or cardiac function.\n\nSide Effects\n\nNEBIVALVE AM is generally well tolerated, but some patients may experience mild side effects, including:\n\nDizziness or lightheadedness\n\nFatigue or weakness\n\nHeadache\n\nFlushing or swelling of ankles (edema)\n\nMild gastrointestinal discomfort\n\nRare but Serious Side Effects\n\nSlow heart rate (bradycardia)\n\nSevere hypotension (low blood pressure)\n\nWorsening of heart failure in susceptible patients\n\nAllergic reactions such as rash or swelling\n\nSeek immediate medical attention if severe symptoms such as fainting, chest pain, or shortness of breath occur.\n\nPrecautions and Warning\n\nPregnancy and Breastfeeding: Use only if clearly indicated and prescribed by a doctor.\n\nHeart Conditions: Inform your doctor if you have heart failure, arrhythmia, or recent heart attack.\n\nKidney or Liver Impairment: Dose adjustment may be necessary.\n\nDiabetes: Nebivolol may mask symptoms of low blood sugar; monitor blood glucose closely.\n\nDrug Interactions: Notify your doctor about all medications, especially other blood pressure drugs, anti-arrhythmics, or diuretics.\n\nAvoid Alcohol: Alcohol may increase the risk of hypotension or dizziness.\n\nRegular Monitoring: Blood pressure and heart rate should be monitored periodically during therapy.\n\nConclusion\n\nNEBIVALVE AM (Nebivolol and S-Amlodipine Tablets) is a safe and effective combination therapy for managing hypertension and reducing cardiovascular risks. By combining Nebivolol’s beta-blocking and vasodilatory effects with S-Amlodipine’s calcium channel blocking action, it provides superior blood pressure control and cardiovascular protection.", "price": 210.0, "discountamount": 63.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2246, "imageuri": "https://productimages.withfloats.com/actual/69400229d51eeda87e74dba0.png", "tileimageuri": "https://productimages.withfloats.com/tile/69400229d51eeda87e74dba0.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-15T12:42:15.327Z", "updatedon": "2025-12-16T05:52:43.351Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nebivolol-and-s-amlodipine-tablets-5-2-5-mg/2246", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NEBIVALVE AM", "category": "CARDIOLOGY", "tags": [ "nebivolol and s-amlodipine tablets", "nebivolol and s-amlodipine tablets uses", "nebivolol and s-amlodipine tablets uses in hindi", "nebivolol", "s-amlodipine tablets", "hypertension (high blood pressure)", "heart attacks", "strokes", "kidney complications", "blood pressure contro", "helps relax blood vessels", "improve blood flow" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e63c17e7475f0f453d4b6e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tenofovir (300mg), Emtricitabine (200mg) & Efavirenz (600 mg)", "description": "TELAVINCE EM is primarily indicated for the management of:\n\nHypertension (High Blood Pressure): Helps in reducing elevated blood pressure effectively.\n\nCardiovascular Risk Reduction: Supports heart health and reduces the risk of stroke, heart attack, and related complications.\n\nPatients requiring combination therapy: Suitable for individuals who need more than one antihypertensive for better blood pressure control.\n\nMechanism of Action:\n\nTELAVINCE EM works through a dual mechanism to control blood pressure:\n\nTelmisartan: Blocks angiotensin II receptors, preventing blood vessel constriction and reducing blood pressure.\n\n[EM Component, e.g., Amlodipine]: Relaxes blood vessels by inhibiting calcium entry into vascular smooth muscles, improving blood flow and reducing strain on the heart.\n\nThe combination ensures better efficacy than monotherapy while maintaining a favorable safety profile.\n\nDosage and Administration:\n\nRecommended Dose: As prescribed by a healthcare professional, typically one tablet daily.\n\nRoute: Oral administration with water.\n\nTiming: Can be taken with or without food, preferably at the same time each day.\n\nAdjustment: Dose may be modified based on individual response and tolerability.\n\nImportant: Always follow your doctor’s instructions. Do not alter the dose or stop medication without medical advice.\n\nKey Benefits of TELAVINCE EM:\n\nEffective blood pressure control with dual-action therapy.\n\nReduces risk of cardiovascular events associated with hypertension.\n\nConvenient once-daily dosing improves patient compliance.\n\nWell-tolerated with a low incidence of side effects.\n\nSuitable for long-term use under medical supervision.\n\nSafety and Precautions:\n\nInform your doctor if you have kidney disease, liver disease, or heart failure.\n\nPregnant or breastfeeding women should avoid use unless advised by a physician.\n\nAvoid excessive salt substitutes containing potassium.\n\nRegular blood pressure and kidney function monitoring is recommended.\n\nDo not use in combination with other angiotensin receptor blockers (ARBs) unless prescribed.\n\nPossible Side Effects:\n\nAlthough TELAVINCE EM is generally well-tolerated, some patients may experience:\n\nDizziness or lightheadedness\n\nFatigue or weakness\n\nMild swelling in ankles or feet\n\nNausea or headache\n\nSeek immediate medical attention if you experience severe side effects such as difficulty breathing, swelling of face or throat, or severe allergic reactions.\n\nStorage Instructions:\n\nStore in a cool, dry place away from direct sunlight.\n\nKeep out of reach of children and pets.\n\nDo not use after the expiry date mentioned on the package.\n\nWhy Choose TELAVINCE EM:\n\nDeveloped by Steris Healthcare Pvt. Ltd, a trusted name in pharmaceutical excellence.\n\nEnsures quality, safety, and efficacy in every tablet.\n\nDesigned for optimal patient compliance with convenient dosing.\n\nBacked by clinical research for managing hypertension effectively.\n\nDisclaimer:\n\nThe information provided here is intended for educational purposes only. TELAVINCE EM should be used only under medical supervision. Consult your healthcare provider for personalized advice. Side effects may vary from person to person.", "price": 4715.0, "discountamount": 1415.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2183, "imageuri": "https://productimages.withfloats.com/actual/68fcce7d2c390674e0a52e8e.png", "tileimageuri": "https://productimages.withfloats.com/tile/68fcce7d2c390674e0a52e8e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-08T10:25:27.075Z", "updatedon": "2025-12-09T06:12:40.527Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tenofovir-300mg-emtricitabine-200mg-efavirenz-600-mg-/2183", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TELAVINCE EM", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "68822dd35b399ba6097ed11b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "glimepiride and metformin hydrochloride tablets", "description": "SEIZMET G0.5 FORTE is a powerful oral antidiabetic medication formulated with a combination of glimepiride and metformin hydrochloride. This dual-action therapy is specifically designed for patients with type 2 diabetes mellitus who are unable to control their blood sugar levels with diet and exercise alone. The combination works in synergy to manage blood glucose effectively, reduce insulin resistance, and improve overall glycemic control.\n\nGlimepiride and metformin hydrochloride tablets are a combination medication used to treat type 2 diabetes. They work by helping the pancreas release more insulin and by reducing the amount of sugar produced by the liver, while also making the body more sensitive to insulin.\n\nWhat is SEIZMET G0.5 FORTE?\nSEIZMET G0.5 FORTE contains two active ingredients:\n\nGlimepiride (0.5 mg): A sulfonylurea class drug that stimulates the beta cells of the pancreas to release insulin.\n\nMetformin Hydrochloride: A biguanide that works primarily by suppressing hepatic glucose production and increasing insulin sensitivity in muscles.\n\nTogether, this combination addresses both insulin deficiency and resistance—two key factors in type 2 diabetes.\n\nUses of SEIZMET G0.5 FORTE:\n\nEffective in managing type 2 diabetes mellitus\n\nHelps in reducing fasting and postprandial blood glucose levels\n\nUsed as monotherapy or in combination with other antidiabetic agents\n\nReduces the risk of diabetic complications such as nephropathy, retinopathy, and cardiovascular disease\n\nSide Effects of SEIZMET G0.5 FORTE:\nLike all medications, glimepiride and metformin hydrochloride tablets may cause side effects in some patients. Common side effects include:\n\nNausea or vomiting\n\nDiarrhea\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness\n\nMetallic taste in the mouth\n\nAbdominal discomfort\n\nIn rare cases, it may cause lactic acidosis, a serious condition related to metformin accumulation.\n\nPrecautions Before Using SEIZMET G0.5 FORTE:\n\nAlways take the medication exactly as prescribed by your doctor.\n\nInform your physician if you have a history of liver or kidney disorders, heart disease, or alcohol abuse.\n\nAvoid excessive alcohol consumption while on this medication as it increases the risk of lactic acidosis.\n\nNot recommended for patients with type 1 diabetes or diabetic ketoacidosis.\n\nRegularly monitor your blood sugar and kidney function.\n\nThis medicine should be used during pregnancy only if absolutely necessary and under medical supervision.\n\nDrug Interactions: What Drugs Interact with SEIZMET G0.5 FORTE?\nCertain medications can interact with glimepiride and metformin, affecting their efficacy or increasing the risk of side effects. These include:\n\nBeta-blockers (e.g., propranolol) – may mask hypoglycemia symptoms\n\nDiuretics – may impair blood sugar control\n\nACE inhibitors – may increase the blood glucose-lowering effect\n\nCorticosteroids – may reduce the effectiveness of the medication\n\nAntipsychotics (e.g., olanzapine)\n\nAlcohol – increases the risk of lactic acidosis\n\nCimetidine – may raise metformin levels in the body\n\nAlways inform your healthcare provider about all medications, supplements, or herbal products you are taking.\n\nConclusion:\nSEIZMET G0.5 FORTE is a trusted, effective choice for managing type 2 diabetes, offering the combined benefits of glimepiride and metformin hydrochloride tablets. With dual mechanisms—enhancing insulin secretion and improving insulin sensitivity—it delivers comprehensive glycemic control. When taken as directed and with regular monitoring, SEIZMET G0.5 FORTE can be a valuable part of a diabetic patient’s treatment regimen, contributing to a healthier, more balanced life.\n\nFor best results, pair this medication with a proper diet, regular physical activity, and periodic blood glucose testing. Always consult your healthcare provider for personalized advice.", "price": 125.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2151, "imageuri": "https://productimages.withfloats.com/actual/68822dd8296c4d19d55e8535.png", "tileimageuri": "https://productimages.withfloats.com/tile/68822dd8296c4d19d55e8535.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-24T12:57:55.385Z", "updatedon": "2025-12-10T06:15:33.607Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-and-metformin-hydrochloride-tablets/2151", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET G 0.5 FORTE", "category": "DIABETIC RANGE", "tags": [ "glimepiride and metformin hydrochloride tablets", "type 2 diabetes mellitus", "blood glucose", "glycemic control", "blood sugar control" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }